A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

NCT03970447 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

2250

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide
DRUG: Lomustine
DRUG: Regorafenib
RADIATION: Radiation
DRUG: Paxalisib
DRUG: VAL-083
DRUG: VT1021
DRUG: Troriluzole
BIOLOGICAL: ADI-PEG 20
DRUG: AZD1390
DRUG: Tinostamustine

Sponsor

Global Coalition for Adaptive Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]